J & J Settlement Pays Off For Nation’s Capital

November 18th, 2013 by Qui Tam

The government’s recent massive settlement with Johnson & Johnson is paying dividends for the residents of Washington, D.C.

The District of Columbia’s Medicaid program will receive more than $3 million out of the $1.2 billion settlement, which resolved four qui tam cases filed in federal court in the Eastern District of Pennsylvania. 

The suits contended that Johnson & Johnson and subsidiary Janssen Pharmaceuticals, Inc., engaged in off-label promotion of antipsychotic drugs Risperdal and Invega.

Leave a Reply